Stephen Ferguson, a scientist at Western University’s Robarts Research Institute, targeted one part of the complex process they think may be involved in the disease’s progression.
“Where a mouse model is very different than a human brain, in principle it could lead to treatments for humans in the future,” said Bev Heim-Myers, the society’s chief executive officer.
Read the full article here.